IL15 and neoplasm: We have designed a novel DCIL-15-based cancer vaccine platform in which DC specifically express human IL-15 transgene and simultaneously produce tumor Aghsp70, and demonstrated its efficacy in effectively inducing prophylactic antitumor immunity.10